Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 2.137\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) CCOC(=O)c1c(NC(=O)c2nc3n(n2)C(C(F)F)CC(C)N3)sc2c1CCCC2
b) CCC(=O)N=C1SC2CS(=O)(=O)CC2N1c1cccc(OC)c1
c) C/C(=N\NC(=O)c1cccc(S(=O)(=O)N2CCCC2)c1)c1ccncc1
d) Cc1cnnc2ccc3c(no[n+]3[O-])c12
e) COc1cc(NC(=O)c2cccc(C)c2)c(Cl)cc1[N+](=O)[O-]
Answer: c. C/C(=N\NC(=O)c1cccc(S(=O)(=O)N2CCCC2)c1)c1ccncc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C/C(=N\NC(=O)c1cccc(S(=O)(=O)N2CCCC2)c1)c1ccncc1
C/C(=N\NC(=O)c1cccc(S(=O)(=O)N2CCCC2)c1)c1ccncc1
N-[(E)-1-pyridin-4-ylethylideneamino]-3-pyrrolidin-1-ylsulfonylbenzamide